- Home
- CMLS vs MBIO Comparison
CMLS vs MBIO Comparison
Compare CMLS & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMLS
- MBIO
- Stock Information
- Founded
- CMLS 2002
- MBIO 2015
- Country
- CMLS United States
- MBIO United States
- Employees
- CMLS N/A
- MBIO N/A
- Industry
- CMLS Broadcasting
- MBIO Biotechnology: Pharmaceutical Preparations
- Sector
- CMLS Consumer Discretionary
- MBIO Health Care
- Exchange
- CMLS Nasdaq
- MBIO Nasdaq
- Market Cap
- CMLS 7.7M
- MBIO 7.3M
- IPO Year
- CMLS 1998
- MBIO N/A
- Fundamental
- Price
- CMLS $0.20
- MBIO $1.24
- Analyst Decision
- CMLS
- MBIO Strong Buy
- Analyst Count
- CMLS 0
- MBIO 1
- Target Price
- CMLS N/A
- MBIO $100.00
- AVG Volume (30 Days)
- CMLS 816.4K
- MBIO 972.6K
- Earning Date
- CMLS 05-01-2025
- MBIO 05-14-2025
- Dividend Yield
- CMLS N/A
- MBIO N/A
- EPS Growth
- CMLS N/A
- MBIO N/A
- EPS
- CMLS N/A
- MBIO N/A
- Revenue
- CMLS $827,076,000.00
- MBIO N/A
- Revenue This Year
- CMLS N/A
- MBIO N/A
- Revenue Next Year
- CMLS $0.79
- MBIO N/A
- P/E Ratio
- CMLS N/A
- MBIO N/A
- Revenue Growth
- CMLS N/A
- MBIO N/A
- 52 Week Low
- CMLS $0.23
- MBIO $1.13
- 52 Week High
- CMLS $3.34
- MBIO $65.00
- Technical
- Relative Strength Index (RSI)
- CMLS 23.73
- MBIO 36.60
- Support Level
- CMLS $0.23
- MBIO $1.13
- Resistance Level
- CMLS $0.31
- MBIO $1.38
- Average True Range (ATR)
- CMLS 0.07
- MBIO 0.12
- MACD
- CMLS -0.00
- MBIO 0.05
- Stochastic Oscillator
- CMLS 4.28
- MBIO 37.93
About CMLS Cumulus Media Inc.
Cumulus Media Inc is an audio-first media company delivering content to over a quarter billion people monthly whenever required. It is a radio broadcasting company combining high-quality local programming with iconic, nationally syndicated media, sports, and entertainment brands to deliver premium content choices to its customers and radio stations affiliated with the Westwood One network and numerous digital channels. The company's revenue is derived from Broadcast radio revenue, Digital revenue, and Other revenue.
About MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.